Humedix Co., Ltd. (KOSDAQ:200670)

South Korea flag South Korea · Delayed Price · Currency is KRW
42,550
-1,500 (-3.41%)
At close: Feb 27, 2026
9.24%
Market Cap 439.12B
Revenue (ttm) 110.99B
Net Income (ttm) 9.06B
Shares Out 10.32M
EPS (ttm) 963.99
PE Ratio 44.14
Forward PE 9.83
Dividend 660.00 (1.55%)
Ex-Dividend Date Apr 2, 2026
Volume 107,743
Average Volume 111,675
Open 43,800
Previous Close 44,050
Day's Range 42,500 - 43,800
52-Week Range 33,050 - 77,200
Beta 0.44
RSI 49.41
Earnings Date Feb 11, 2026

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea. [Read more]

Sector Healthcare
Founded 2002
Employees 248
Stock Exchange KOSDAQ
Ticker Symbol 200670
Full Company Profile

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.

Financial Statements

News

There is no news available yet.